QURE Competitors & Alternatives
Compare Uniqure NV with similar stocks in the same industry
Biotechnology
QURE
Main Stock$47.53
Tradestie Score
50
Market Cap
$3.39B
Revenue Growth
0.1%
Analyst Upside
+46.6%
Top Competitors
238 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
MIRM
Mirum Pharmaceuticals, Inc. Common Stock
|
$97.55
|
$3.67B | - | 68 | Compare |
|
ADMA
ADMA Biologics, Inc.
|
$9.61
|
$3.59B | 13.9 | 42 | Compare |
|
ACAD
Acadia Pharmaceuticals Inc.
|
$29.71
|
$3.58B | 13.6 | 47 | Compare |
|
LGND
Ligand Pharmaceuticals Inc.
|
$281.58
|
$3.49B | 29.9 | 56 | Compare |
|
TLX
Telix Pharmaceuticals Limited American Depositary Shares
|
$11.65
|
$3.40B | - | 40 | Compare |
|
SRRK
Scholar Rock Holding Corporation Common Stock
|
$58.10
|
$3.33B | - | 36 | Compare |
|
NAMS
NewAmsterdam Pharma Company N.V. Ordinary Shares
|
$26.90
|
$3.31B | - | 56 | Compare |
|
SLNO
Soleno Therapeutics, Inc. Common Stock
|
$53.01
|
$3.20B | 27.5 | 48 | Compare |
|
MLYS
Mineralys Therapeutics, Inc. Common Stock
|
$25.40
|
$3.09B | - | 41 | Compare |
|
VKTX
Viking Therapeutics, Inc
|
$33.36
|
$3.08B | - | 43 | Compare |
More QURE Analysis
Data updated: Aug 24, 2026 | Industry: Biotechnology (SIC 2834)
238 stocks in this industry